GETI-B:STO
Getinge publ AB
SEKÂ 247.20
arrow_downward
-0.32%(-0.80) 1D
Oct 1, 5:29:44 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GETI-B...
Open
SEKÂ 246.00
High
SEKÂ 250.30
Low
SEKÂ 245.10
Mkt. cap
62.83B
Avg. vol.
573.73K
Volume
361.28K
Dividend
1.92%
Quarterly dividend
SEKÂ 1.19
Ex-dividend date
Apr 22, 2026
P/E ratio
25.18
52-wk high
SEKÂ 251.40
52-wk low
SEKÂ 175.90
EPS
SEKÂ 9.82
Shares outstanding
254.15M
No. of employees
12K
Open
SEKÂ 246.00
High
SEKÂ 250.30
Low
SEKÂ 245.10
Mkt. cap
62.83B
Avg. vol.
573.73K
Volume
361.28K
Dividend
1.92%
Quarterly dividend
SEKÂ 1.19
Ex-dividend date
Apr 22, 2026
P/E ratio
25.18
52-wk high
SEKÂ 251.40
52-wk low
SEKÂ 175.90
EPS
SEKÂ 9.82
Shares outstanding
254.15M
No. of employees
12K
News stories
From web sources and news partners
AD HOC NEWS
·
15 hours ago
Getinge B stock ahead of the Xetra open: prior close EUR 21.81 on September 30, 2026
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB